{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T14:52:16Z","timestamp":1781275936783,"version":"3.54.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiology Clinics"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.ccl.2019.04.002","type":"journal-article","created":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T09:16:00Z","timestamp":1557911760000},"page":"267-273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Treatment of Cardiorenal Syndrome"],"prefix":"10.1016","volume":"37","author":[{"given":"Jack","family":"Rubinstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darek","family":"Sanford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.ccl.2019.04.002_bib1","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2008.07.051","article-title":"Cardiorenal syndrome","volume":"52","author":"Ronco","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.ccl.2019.04.002_bib2","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.cardfail.2007.04.008","article-title":"Worsening renal function and prognosis in heart failure: systematic review and meta-analysis","volume":"13","author":"Damman","year":"2007","journal-title":"J\u00a0Card Fail"},{"issue":"1","key":"10.1016\/j.ccl.2019.04.002_bib3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jacc.2003.07.031","article-title":"Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure","volume":"43","author":"Forman","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.ccl.2019.04.002_bib4","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1005419","article-title":"Diuretic strategies in patients with acute decompensated heart failure","volume":"364","author":"Felker","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ccl.2019.04.002_bib5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jchf.2015.08.007","article-title":"Impact of dietary sodium restriction on heart failure outcomes","volume":"4","author":"Doukky","year":"2016","journal-title":"JACC Heart Fail"},{"issue":"1","key":"10.1016\/j.ccl.2019.04.002_bib6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jacc.2005.03.051","article-title":"In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"45","author":"Abraham","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"13","key":"10.1016\/j.ccl.2019.04.002_bib7","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1001\/jama.294.13.1625","article-title":"Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness","volume":"294","author":"Binanay","year":"2005","journal-title":"JAMA"},{"issue":"13","key":"10.1016\/j.ccl.2019.04.002_bib8","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.jacc.2007.08.072","article-title":"Cardiorenal interactions: insights from the ESCAPE trial","volume":"51","author":"Nohria","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2019.04.002_bib9","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.amjmed.2014.06.009","article-title":"Hemoconcentration-guided diuresis in heart failure","volume":"12","author":"Vaduganathan","year":"2014","journal-title":"Am J Med"},{"key":"10.1016\/j.ccl.2019.04.002_bib10","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1527-5299.2002.0758.x","article-title":"Pharmacotherapy in congestive heart failure: diuretic resistance and strategies to overcome resistance in patients with congestive heart failure","volume":"8","author":"Ravnan","year":"2002","journal-title":"Congest Heart Fail"},{"issue":"6","key":"10.1016\/j.ccl.2019.04.002_bib11","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jacc.2006.07.073","article-title":"Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure","volume":"49","author":"Costanzo","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2019.04.002_bib12","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1056\/NEJMoa1210357","article-title":"Ultrafiltration in decompensated heart failure with cardiorenal syndrome","volume":"367","author":"Bart","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2019.04.002_bib13","first-page":"e240","article-title":"2013 ACCF\/AHA guideline for the management of heart failure","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2019.04.002_bib14","first-page":"49","article-title":"Novel therapeutic option for refractory heart failure in elderly patients with chronic kidney disease by incremental peritoneal dialysis","volume":"55","author":"Nakayama","year":"2010","journal-title":"J\u00a0Cardiol"},{"key":"10.1016\/j.ccl.2019.04.002_bib15","first-page":"1531","article-title":"Intravenous Nesiritide vs nitroglycerin for treatment of decompensated heart failure: a randomized controlled trial","volume":"287","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ccl.2019.04.002_bib16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1100171","article-title":"Effect of Nesiritide in patients with acute decompensated heart failure","volume":"365","author":"O\u2019Connor","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"10.1016\/j.ccl.2019.04.002_bib17","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.jacc.2007.03.071","article-title":"Impact of Nesiritide on renal function in patients with acute decompensated heart failure and pre-existing renal\u00a0dysfunction","volume":"50","author":"Witteles","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"17","key":"10.1016\/j.ccl.2019.04.002_bib18","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1001\/jama.298.17.2009","article-title":"Effects of Tezosentan on symptoms and clinical outcomes in patients with acute heart failure","volume":"298","author":"McMurray","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ccl.2019.04.002_bib19","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jacc.2008.02.083","article-title":"Sodium nitroprusside for advanced low-output heart failure","volume":"52","author":"Mullens","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.ccl.2019.04.002_bib20","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1067\/mhj.2001.119610","article-title":"Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: hemodynamic efficacy, clinical outcome, and economic impact","volume":"142","author":"Yamani","year":"2001","journal-title":"Am Heart J"},{"issue":"9328","key":"10.1016\/j.ccl.2019.04.002_bib21","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0140-6736(02)09455-2","article-title":"Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomized double-blind trial","volume":"360","author":"Follath","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ccl.2019.04.002_bib22","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1001\/jama.297.17.1883","article-title":"Levosimendan vs dobutamine for patients with acute decompensated heart failure","volume":"297","author":"Mebazaa","year":"2007","journal-title":"JAMA"},{"issue":"Suppl 4","key":"10.1016\/j.ccl.2019.04.002_bib23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2165\/00003495-199000394-00004","article-title":"Role of the kidney in congestive heart failure. Relationship of cardiac index to kidney function","volume":"39","author":"Ljungman","year":"1990","journal-title":"Drugs"},{"key":"10.1016\/j.ccl.2019.04.002_bib24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1161\/CIRCHEARTFAILURE.107.746933","article-title":"Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure (OPTIME-CHF)","volume":"1","author":"Klein","year":"2008","journal-title":"Circ Heart Fail"},{"issue":"23","key":"10.1016\/j.ccl.2019.04.002_bib25","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1001\/jama.2013.282190","article-title":"Low-dose dopamine or low-dose Nesiritide in acute heart failure with renal dysfunction","volume":"310","author":"Chen","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ccl.2019.04.002_bib26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jchf.2012.12.004","article-title":"Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure","volume":"1","author":"Packer","year":"2013","journal-title":"JACC Heart Fail"},{"issue":"7","key":"10.1016\/j.ccl.2019.04.002_bib27","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.cardfail.2008.03.009","article-title":"Cardiac resynchronization therapy improves renal function in human heart failure with reduced glomerular filtration rate","volume":"14","author":"Boerrigter","year":"2008","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.ccl.2019.04.002_bib28","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1097\/01.ASN.0000135121.81744.75","article-title":"Renal function, digoxin therapy, and heart failure outcomes: evidence from the digoxin intervention group trial","volume":"15","author":"Shlipak","year":"2004","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ccl.2019.04.002_bib29","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","article-title":"Effects of Enalapril on mortality in severe congestive heart failure","volume":"316","year":"1987","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.ccl.2019.04.002_bib30","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of Enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","author":"Yusuf","year":"1991","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.ccl.2019.04.002_bib31","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10741-011-9295-6","article-title":"ACE inhibitor therapy for heart failure in patients with impaired renal function: a review of the literature","volume":"18","author":"Valika","year":"2013","journal-title":"Heart Fail Rev"},{"issue":"Suppl B","key":"10.1016\/j.ccl.2019.04.002_bib32","first-page":"25B","article-title":"Cardiorenal syndrome in heart failure: a cardiologist\u2019s perspective","volume":"24","author":"Liu","year":"2008","journal-title":"Can J Cardiol"},{"issue":"21","key":"10.1016\/j.ccl.2019.04.002_bib33","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1093\/eurheartj\/ehr170","article-title":"Mineralocorticoid receptor antagonism: therapeutic potential in acute heart failure syndromes","volume":"32","author":"Albaghdadi","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ccl.2019.04.002_bib34","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus Enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.ccl.2019.04.002_bib35","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1001\/jama.2013.1954","article-title":"Effect of Aliskiren on post-discharge mortality and heart failure readmissions among patients hospitalized for heart failure","volume":"309","author":"Gheorghiade","year":"2013","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ccl.2019.04.002_bib36","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0735-1097(01)01516-9","article-title":"Metoprolol controlled release\/extended release in patients with severe heart failure: analysis of the experience in the MERIT-HF study","volume":"38","author":"Goldstein","year":"2001","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9146","key":"10.1016\/j.ccl.2019.04.002_bib37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"The cardiac insufficiency bisprolol study II (CIBIS II): a randomized trial","volume":"353","year":"1999","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ccl.2019.04.002_bib38","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/eurheartj\/ehi115","article-title":"Randomized trial to determine the effect of nebivolol on mortality and cardiovascular admission in elderly patients with heart failure (SENIORS)","volume":"26","author":"Flather","year":"2005","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.ccl.2019.04.002_bib39","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/S0735-1097(03)00241-9","article-title":"Carvedilol increases two-year survivalin in dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial","volume":"41","author":"Cice","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2019.04.002_bib40","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1001\/jama.291.16.1963","article-title":"Effects of Tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure","volume":"291","author":"Gheorghiade","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ccl.2019.04.002_bib41","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","article-title":"Effects of oral Tolvaptan in patients hospitalized for worsening heart failure","volume":"297","author":"Konstam","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ccl.2019.04.002_bib42","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2147\/TCRM.S61551","article-title":"The role of erythropoietin stimulating agents in anemic patients with heart failure: solved and unresolved questions","volume":"10","author":"Palazzuoli","year":"2014","journal-title":"Ther Clin Risk Management"},{"issue":"4","key":"10.1016\/j.ccl.2019.04.002_bib43","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1161\/CIRCULATIONAHA.107.698514","article-title":"Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure","volume":"117","author":"Ghali","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2019.04.002_bib44","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1056\/NEJMoa1214865","article-title":"Treatment of anemia with darbeopotein alfa in systolic heart failure","volume":"368","author":"Swedberg","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2019.04.002_bib45","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa0912613","article-title":"Rolofylline, an adenosine A1-receptor antagonist, in\u00a0acute heart failure","volume":"363","author":"Massie","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.ccl.2019.04.002_bib46","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.cardfail.2014.06.353","article-title":"Effects of glucocorticoids in potentiating diuresis in heart failure patients with diuretic resistance","volume":"20","author":"Liu","year":"2014","journal-title":"J\u00a0Card Fail"},{"issue":"2","key":"10.1016\/j.ccl.2019.04.002_bib47","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jacc.2012.11.005","article-title":"Effect of Serelaxin on cardiac, renal, and hepatic biomarkers in the relaxin in acute heart failure (RELAX-AHF) development program: correlation with outcomes","volume":"16","author":"Metra","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2019.04.002_bib48","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2019.04.002_bib49","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1016\/S1262-3636(17)30068-X","article-title":"GLP-1 receptor agonists and heart failure in diabetes","volume":"43","author":"Scheen","year":"2017","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.ccl.2019.04.002_bib50","doi-asserted-by":"crossref","first-page":"i47","DOI":"10.1093\/rheumatology\/kex432","article-title":"Cardiac and renal protective effects of urate-lowering therapy","volume":"57","author":"Richette","year":"2018","journal-title":"Rheumatology"},{"issue":"9","key":"10.1016\/j.ccl.2019.04.002_bib51","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.jacc.2017.12.052","article-title":"Cardiovascular risks of probenecid versus allopurinol in older patients with Gout","volume":"71","author":"Kim","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2019.04.002_bib52","doi-asserted-by":"crossref","first-page":"e007148","DOI":"10.1161\/JAHA.117.007148","article-title":"Probenecid improves cardiac function in patients with heart failure with reduced ejection fraction in\u00a0vivo and cardiomyocyte calcium sensitivity in\u00a0vitro","volume":"7","author":"Robbins","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.ccl.2019.04.002_bib53","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3389\/fphys.2018.00849","article-title":"Probenecid pre-treatment downregulates the kidney Cl\/HCO3 exchanger (pendrin) and potentiates hydrochlorothiazide-induced diuresis","volume":"9","author":"Barone","year":"2018","journal-title":"Front Physiol"}],"container-title":["Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865119300281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865119300281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:50:07Z","timestamp":1760007007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733865119300281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0733865119300281"],"URL":"https:\/\/doi.org\/10.1016\/j.ccl.2019.04.002","relation":{},"ISSN":["0733-8651"],"issn-type":[{"value":"0733-8651","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Cardiorenal Syndrome","name":"articletitle","label":"Article Title"},{"value":"Cardiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccl.2019.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}